Stories from Surgical Aesthetics
Wednesday, April 12, 2017 - 12:38
Galderma has released the results from two Phase 4 clinical studies of Restylane Refyne and Restylane Defyne, the most recent U.S. additions to it Restylane family of soft tissue fillers. The Natural Expression study found that natural facial expression was maintained in 95% (60/63) of subjects (primary objective). The Dynamic Strain study found that 83% (25/30) of subjects had enhanced attractiveness, looked younger and maintained expression following injections of Restylane Refyne and Restylane Defyne.
Tuesday, April 11, 2017 - 10:15
Improve your bottom line by identifying and eliminating poorly performing products and servicesBy Cheryl WhitmanAs any good gardener knows, in order to have a healthy tree that bears plentiful, quality fruit, the tree must be regularly pruned. This holds true for businesses as well. In order to maintain a healthy bottom line, practice owners must be willing to cut away the deadwood in their facilities—those products and services that simply don’t carry their weight. Offerings that are not selling and those that contribute a below average return on investment (ROI) can damage cash flow—and...
Wednesday, April 5, 2017 - 10:58
Merz Pharma, a global provider of aesthetic products and neurotoxins, has appointed Bob Rhatigan as president and chief executive officer (CEO) of Merz North America and Patrick Urban as chief commercial officer, effective immediately. Both Rhatigan and Urban will be based in Raleigh, North Carolina.
Wednesday, April 5, 2017 - 10:54
Aesthetic device manufacturer Syneron Medical has entered into an agreement with Apax Partners, a global private equity advisory firm, under which an affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of Syneron-Candela for $11.00 per share in cash in a transaction valued at approximately $397 million.
Wednesday, April 5, 2017 - 10:50
On Monday, March 27, the American Skin Association (ASA) celebrated its 30 years anniversary by presenting awards to three honorees who have made a significant impact in the areas of skin health and research. The ASA and its affiliates have funded more than $50 million in grants to support the work of more than 300 promising young scientists. In addition, the organization works to educate the public on skin health through its ASA Education Council. Monday night's honorees included:
Monday, April 3, 2017 - 11:06
Launching a private label line.By Shelley Moench-Kelly, MBARetail skincare products offer several benefits to aesthetic patients and practices. They help patients protect the health of their skin and maintain the results of in-office treatments, while providing an additional source of ongoing revenue for the practice. The challenge is that with so many online and brick-and-mortar retailers offering high-end skin care, patients naturally shop for the best deals on their favorite brands.
Thursday, March 30, 2017 - 11:00
FEATURES Soft tissue fillers for midface rejuvenation »Starting in the Middle
Thursday, March 30, 2017 - 09:36
Adipose-derived stem cells (ASCs) taken from the same patients years apart maintained their numbers and ability to differentiate, suggesting that age does not significantly affect the quality of ASCs.
Thursday, March 30, 2017 - 09:32
The American Academy of Dermatology (AAD) has elected new officers and board members, who took office following the academy’s annual meeting in March. They include: President-Elect: George J. Hruza, MD, MBA, FAAD. Dr. Hruza is as an adjunct professor of dermatology at St. Louis University. He is currently an assistant editor of the Journal of the American Academy of Dermatology and vice chair of SkinPAC, which works to raise the visibility of dermatology as a leader among physician specialties and within the health policy community.
Thursday, March 30, 2017 - 09:29
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) Injection from Regeneron Pharmaceuticals, and Sanofi for the treatment of adults with moderate-to-severe atopic dermatitis (AD).
Thursday, March 23, 2017 - 11:50
Valeant Pharmaceuticals International has closed its previously announced refinancing transactions. These include its offering of $1.25 billion aggregate principal amount of 6.50% senior secured notes due in 2022, and $2 billion aggregate principal amount of 7% senior secured notes due in 2024. The company borrowed an additional $3 billion (approximately) of new term loans maturing in 2022.
Thursday, March 23, 2017 - 11:48
Postmenopausal women with hirsutism are less likely to experience paradoxical hypertrichosis following treatment with an alexandrite laser if they snip their hair rather than shave it prior to treatment. Researchers Robabeh Alijanpour, MD, and Fatemeh Aliakbarpour, DDS, randomly divided 129 premenopausal women affected by hirsutism into two groups. Group A (66 patients) shaved their hair prior to laser treatment and Group B (63 patients) shortened their hair using scissors.
Thursday, March 23, 2017 - 11:24
Allergan’s Juvéderm Vollure XC, known as Volift outside of the U.S., has received FDA marketing clearance for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21.
Thursday, March 23, 2017 - 09:26
Physicians share their experiences with the growing range of noninvasive fat reduction technologies.By Maryann HammersIn the five years since Zeltiq’s CoolSculpting device first received U.S. Food and Drug Administration (FDA) approval for the noninvasive destruction of fat in the abdomen, the medical aesthetics industry has seen an array of FDA-cleared fat reduction technologies enter the market. Each is designed to permanently thin down thighs, blast away back flab, whittle middles or slim chin chub with minimal or no downtime.
Thursday, March 23, 2017 - 09:12
A new organization is using a community-based business model to help practice owners build their business management skills.By Inga HansenAre you struggling with the challenges of employee management? Wondering how to track and improve the patient experience? Perhaps you are eyeing retirement and looking for ways to maximize the value of your practice. If so, a new organization called the Dermatology Business Accelerator (DBA) may be of help.
Wednesday, March 22, 2017 - 12:47
Dermatologist Susan Stuart, MD, and plastic surgeon Richard Chaffoo, MD, joined forces in life and in private practice.By Keith LoriaWhat happens when a couple in love goes into business together? For dermatologist Susan Stuart, MD, and her husband, plastic surgeon Richard Chaffoo, MD, the answer is happy patients and private practice success.
Wednesday, March 22, 2017 - 12:27
Prepare your practice in the event of catastrophe and optimize your assets in expectation of retirement.By Mara L. Shorr and Jay A. ShorrWhen you graduated medical school, retirement was likely the last thing on your mind. But if you have since moved on to private practice ownership, it’s time to consider what will happen to your practice in the event of death, disability or retirement. Keep in mind, the unique nature of medical practice ownership necessitates pre-planning for both the expected and unexpected. “Succession planning is more complex in the medical field because only licensed...
Wednesday, March 22, 2017 - 10:55
Main Image: Replenix Pure Hydration Moisture Balm from Topix Pharmaceuticals targets severe dryness and signs of aging with the brand’s Triple Layer Moisture Technology, a blend of humectant hyaluronic acid, emollient vitamin E and squalane, and proprietary Biomimetic Ceramide Complex. Other actives include antioxidants bisabolol and resveratrol to soothe the skin while guarding against environmental damage, and tetrapeptide-21 to minimize the appearance of fine lines and wrinkles. Contact: 800.445.2595, www.topixpharm.com. No, don't share this with BeautyEtcArticles: ...